AHR: financial statements from SEC — TradeAlmanac

AHR

American Healthcare REIT, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	651m	573m	543m	541m	524m	505m
Cost of revenue	512m	455m	426m	432m	417m	403m
Selling, general and administrative	18m	14m	15m	13m	12m	12m
Operating expenses	612m	530m	496m	502m	490m	473m
Interest expense	19m	20m	23m	23m	30m	31m
Pre-tax income	23m	36m	11m	−6m	−3m	4m
Income tax	−525,000	−21m	732,000	604,000	263,000	686,000
Net income	24m	56m	10m	−7m	−4m	2m
Earnings per share	0.13	0.33	0.06	−0.04	−0.03	0.01
Earnings per share, diluted	0.13	0.33	0.06	−0.04	−0.03	0.01
Weighted average shares	187m	169m	160m	157m	134m	131m
Weighted average shares, diluted	188m	170m	161m	157m	134m	131m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	119m	115m	147m	133m	86m	77m	68m	52m
Receivables	242m	204m	189m

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	81m	—	—	61m	—	—
Depreciation and amortisation	67m	49m	42m	41m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)